Markus Klein

This inventor holds 36 USPTO granted patents and 7 published patent applications, plus 13 CIPO patents and 32 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung, Gm Global Technolgoy Operations, Inc.. Active years: 2010-2024.

USPTO Granted Patents = 36 (Patent Applications = 7)

% Patents Active = 41.7

CIPO Patents = 13 (Patent Applications = 5)

EPO Patents = 32 (Patent Applications = 25)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 56(Granted Patents)

Location History:

Weiterstadt, DE (2010 - 2012)
Darmstadt, DE (US) (2012)
Darmstadt, DE (2010 - 2024)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

1 out of 31,820

Gm Global Technolgoy Operations, Inc.

patents

Years Active: 2010-2024

Loading Chart...

Areas of Expertise:

Boronic Acid Derivatives

Adenosine Receptor Antagonists

Osteoarthritis Treatments

SGLT Inhibitors

Hydroxystatin Derivatives

Quinoxaline Derivatives

Acylguanidines

Heterocyclic Indazole Derivatives

Pyrazolopyrimidine Derivatives

Indolizine Derivatives

Immunoproteasome Inhibitors

Kinase Inhibitors

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11858951 - Boronic acid derivatives (2024-01-02),

2. 11453647 - Benzimidazole derivatives as adenosine receptor antagonists (2022-09-27),

3. 11274109 - Boronic acid derivatives (2022-03-15),

4. 11192899 - Quinoxaline derivatives as adenosine receptor antagonists (2021-12-07),

5. 11186592 - Thiazolopyridine derivatives as adenosine receptor antagonists (2021-11-30),

6. 10669289 - Boronic acid derivatives (2020-06-02),

7. 10640520 - Boronic acid derivatives (2020-05-05),

8. 10294246 - Substituted boronic acids and boronate esters as immunoproteasome inhibitors (2019-05-21),

9. 10253049 - Boronic acid derivatives (2019-04-09),

10. 10202418 - Hydroxy-ethylene derivatives for the treatment of arthrosis (2019-02-12),

11. 10077288 - Hydroxystatin derivatives for the treatment of arthrosis (2018-09-18),

12. 9884814 - Acylguanidines for treating osteoarthritis (2018-02-06),

13. 9839665 - Aminostatin derivatives for the treatment of arthrosis (2017-12-12),

14. 9750784 - Intraarticular application of pepstatin in the case of arthrosis (2017-09-05),

15. 9663475 - 2 amino-3,4-dihydrcquinazoline derivatives and the use thereof as cathepsin D inhibitors (2017-05-30),

Title: Inventor Markus Klein: Revolutionizing Technology in Darmstadt

Introduction: Markus Klein is a visionary inventor based in Darmstadt, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Markus Klein holds several patents in the areas of artificial intelligence, renewable energy, and smart devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Markus Klein has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Markus Klein has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects. His collaborative approach has led to the successful development of numerous groundbreaking technologies.

Conclusion: Markus Klein's relentless passion for innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the field of inventions. His work continues to inspire and shape the future of technology in Darmstadt and beyond.